Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 57

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 57
---
 and Preferred Shares, as the case may be, with respect to the matters to be considered at the NLS Meeting. This proxy statement/prospectus and its annexes contain important information about the proposed Merger, Merger Agreement and other matters to be acted upon at the NLS Meeting. You should read this proxy statement/prospectus and its annexes carefully and in their entirety. This proxy statement/prospectus constitutes both a proxy statement and a prospectus of NLS. It is a proxy statement because the NLS Board is soliciting proxies from NLS’s shareholders in connection with the NLS Meeting. It is a prospectus because NLS will issue NLS Common Shares in exchange for outstanding Kadimastem Ordinary Shares in the Merger. This proxy statement/prospectus is not intended to be and is not a prospectus for purposes of Israeli Securities Law, and the ISA has not approved this proxy statement/prospectus. For a more complete description of the Merger, please see the section entitled “ The Merger Proposal (Proposal 1) — The Merger Agreement” in this proxy statement/prospectus. iii Q.What matters will be considered and voted on at the NLS Meeting? There are 15 matters proposed by the NLS Board, scheduled for a vote at the NLS Meeting: 1.To approve, on an advisory basis, the Merger Agreement. 2.To approve (i) the reduction of the par value from CHF 0.03 per NLS Common Share, per Preferred Share, and per PPC to (not less than) CHF 0.003 per NLS Common Share, per Preferred Share and per PPC, and book any reduction amount into capital contribution reserves, (ii) the increase of the share capital and the participation capital by such minimum number of NLS Common Shares, Preferred Shares, and PPCs that allows the reverse split under Proposal 2(iii) to take place without fractional Common Shares, Preferred Shares, and PPCs against payment on behalf of the Company of the nominal amount and with exclusion of subscription rights of the shareholders, (iii) the reverse split of the Ordinary Shares, the Preferred Shares, and the PPCs by a reverse split ratio within a range of two -for-one(2:1) to twenty -for-one(20:1), and (iv) the increase of the share capital of the Company, by way of an ordinary capital increase, by up to 3,500,000 NLS Common Shares (which number is